Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines

Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinica...

Full description

Bibliographic Details
Main Authors: Julia E. Morgan, Sara C. Wilson, Benjamin J. Travis, Kathryn H. Bagri, Kathleen T. Pagarigan, Hannah M. Belski, Cecelia Jackson, Kevin M. Bounader, Jessica M. Coppola, Eden N. Hornung, James E. Johnson, Hilary S. McCarren
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/full
id doaj-82e115ebae2b479090b5715d10580dce
record_format Article
spelling doaj-82e115ebae2b479090b5715d10580dce2021-09-10T04:27:17ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-09-011510.3389/fnins.2021.732213732213Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment GuidelinesJulia E. Morgan0Sara C. Wilson1Benjamin J. Travis2Kathryn H. Bagri3Kathleen T. Pagarigan4Hannah M. Belski5Cecelia Jackson6Kevin M. Bounader7Jessica M. Coppola8Eden N. Hornung9James E. Johnson10Hilary S. McCarren11Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesComparative Pathology Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties.https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/fullstatus epilepticusrefractoryseizurenerve agentorganophosphatesoman
collection DOAJ
language English
format Article
sources DOAJ
author Julia E. Morgan
Sara C. Wilson
Benjamin J. Travis
Kathryn H. Bagri
Kathleen T. Pagarigan
Hannah M. Belski
Cecelia Jackson
Kevin M. Bounader
Jessica M. Coppola
Eden N. Hornung
James E. Johnson
Hilary S. McCarren
spellingShingle Julia E. Morgan
Sara C. Wilson
Benjamin J. Travis
Kathryn H. Bagri
Kathleen T. Pagarigan
Hannah M. Belski
Cecelia Jackson
Kevin M. Bounader
Jessica M. Coppola
Eden N. Hornung
James E. Johnson
Hilary S. McCarren
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
Frontiers in Neuroscience
status epilepticus
refractory
seizure
nerve agent
organophosphate
soman
author_facet Julia E. Morgan
Sara C. Wilson
Benjamin J. Travis
Kathryn H. Bagri
Kathleen T. Pagarigan
Hannah M. Belski
Cecelia Jackson
Kevin M. Bounader
Jessica M. Coppola
Eden N. Hornung
James E. Johnson
Hilary S. McCarren
author_sort Julia E. Morgan
title Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
title_short Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
title_full Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
title_fullStr Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
title_full_unstemmed Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
title_sort refractory and super-refractory status epilepticus in nerve agent-poisoned rats following application of standard clinical treatment guidelines
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2021-09-01
description Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties.
topic status epilepticus
refractory
seizure
nerve agent
organophosphate
soman
url https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/full
work_keys_str_mv AT juliaemorgan refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT saracwilson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT benjaminjtravis refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT kathrynhbagri refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT kathleentpagarigan refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT hannahmbelski refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT ceceliajackson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT kevinmbounader refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT jessicamcoppola refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT edennhornung refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT jamesejohnson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
AT hilarysmccarren refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines
_version_ 1717758743117037568